Skip to main content

Imagene AI

Biotechnology Research

Imagene AI delivers precision Oncology Intelligence through robust multimodal foundation models and proprietary real-world data, accelerating biomarker discovery, patient stratification, response prediction, and companion diagnostic development. From H&E-based molecular profiling to AI-IHC companion diagnostics, Imagene AI develops AI-powered pathology assays that translate biological insight into patient selection and diagnostic strategies.

Is Imagene AI hiring?

Yes. As of November 3, 2026, Imagene AI has 7 open roles on Metaintro.

Open roles

Newest first. Pay shown when the posting lists it.

Hiring pattern

How fast Imagene AI is adding roles, and how they're set up.

New roles each monthRoles first posted in the month

7
0
OctoberNovember
November: 0 new roles.

How roles are set upShare of open roles

14%
86%
RemoteOn-site
14% of roles are hybrid or remote.

Customers

All 2 companies Imagene AI names as customers.

Customers2

  • Oracle Health and Life Sciences
  • Director of Thoracic Oncology

What their customers say

Quotes from people at Imagene AI's customers.

“Cancer continues to have a devastating impact on individuals and families, but with advancements in cloud and AI we have an opportunity to help change this narrative. We are proud to be working with companies like Imagene AI to support breakthroughs in oncology that can help improve outcomes for those afflicted with this disease.”

Seema Verma · EVP & GM · Oracle Health and Life Sciences

“CanvOI transforms our approach to healthcare and disease understanding. By providing access to comprehensive oncology intelligence in the cloud, it enables researchers to develop answers quicker and more efficiently. This technology marks a new era of cancer research that pushes us closer to a future where cancer is a manageable condition.”

Dr. David Agus · Founding Director and Co-CEO

“Tempus is committed to broadly offering AI-enabled diagnostics in an effort to improve patient outcomes. This collaboration with Imagene strengthens our diagnostic offerings and allows us to provide clinicians more actionable data that may lead to additional testing.”

Chris Scotto DiVetta · Senior Vice President of AI Products

“The ability to use Imagene’s AI technology under research is a game-changer. It allowed us to bypass the usual lengthy waiting period associated with comprehensive genomic profiling. This technology is revolutionizing the way we diagnose patients, with the potential to improve outcomes and save lives.”

“Imagene’s AI-based biomarker detection shows great promise for significantly reducing the waiting time for patients to begin targeted therapies. This kind of technology can lead to better and earlier cancer care for patients no matter where they live.”

Dr. David R. Braxton · Chief of Molecular Pathology Services
Show 2 more quotes

“Oncologists already use clinical features like race and smoking status to manage decision-making when treatment delays pending molecular results are likely to be appropriate. I would definitely use a science-forward, reliable, and ultra-rapid AI test to enhance this process in supporting an informed clinical decision.”

Dr. Ross Camidge · Professor of Medicine · Director of Thoracic Oncology

“We have reached another significant milestone in digital pathology with this ability to detect biomarkers by AI. The use of deep learning algorithms is changing the world of diagnosis, and in certain cases can drastically shorten the cost and time to treatment. I am excited about the growing number of patients who were able to receive rapid diagnoses and treatment.”

AI launches and partners

What Imagene AI has launched and who it works with on AI.

  • PartnerMindpeak CollaborationImagene AI is bringing its Lung Prediction Panel onto Mindpeak’s peakDeploy platform, giving laboratories broader access to image-based biomarker profiling.
  • PartnerDaiichi Sankyo CollaborationImagene AI and Daiichi Sankyo are collaborating on multimodal biomarker discovery and response prediction, including quantitative IHC scoring for select ADC development programs.
  • LaunchAI Assay & CDx DevelopmentImagene advances companion diagnostic programs through quantitative AI assay development, clinical validation, regulatory execution, and deployment across preferred CRO providers worldwide.
  • LaunchOI DiscoverOI Discover develops an AI response prediction model, applies it to Imagene's multimodal data lake, and identifies and prioritizes biomarker candidates.

Skills they ask for

Most frequent across open postings.

Tech stack

Libraries
jQuery
Font Awesome
Swiper
Security
CookieYes
CMS
WordPress
HubSpot CMS
Analytics
Google Analytics 4
Google Tag Manager
Marketing
HubSpot

Company facts

Industry
Biotechnology Research
Sector (NAICS)
Professional, Scientific, and Technical Services
Peer
Amgen

Roles by location

Where Imagene AI is hiring. Pick a city to see its roles.

Similar companies

Companies in the same industry as Imagene AI that are hiring now.

Questions about Imagene AI

Is Imagene AI hiring?
Yes. As of November 3, 2026, Imagene AI has 7 open roles on Metaintro. The most are in Artificial Intelligence/Machine Learning (1), Biotechnology and Pharmaceuticals (1), and Business Development (1).
Where is Imagene AI hiring?
Imagene AI is hiring in Tel Aviv and Florida, United States, with the most open roles in Tel Aviv.
Does Imagene AI offer remote or hybrid work?
0% of open roles are hybrid and 14% are remote.
Who are Imagene AI's customers?
Imagene AI names 2 customers, including Oracle Health and Life Sciences and Director of Thoracic Oncology.
Return to navigation